LIPIODOL

LOE Approaching

ethiodized oil

NDAINTRALYMPHATIC, INTRAUTERINEOILPriority Review
Approved
Mar 1954
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5

Mechanism of Action

X-Ray Contrast Activity

Pharmacologic Class:

Radiographic Contrast Agent

Clinical Trials (5)

NCT06563908N/ANot Yet Recruiting

Lipiodol Prior to FET (LIFE)

Started Aug 2024
784 enrolled
IVFFrozen Embryo TransferHysterosalpingography
NCT04733092Phase 1Completed

Safety and Efficacy of a Lipiodol Emulsion for the Embolization of Hypervascularizations in Patients With Knee Pain (LipioJoint1)

Started Mar 2021
22 enrolled
Knee Osteoarthritis
NCT03727633Phase 2Recruiting

Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion

Started Jul 2018
53 enrolled
Carcinoma, Hepatocellular
NCT02625389Phase 4Completed

A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures

Started Nov 2017
132 enrolled
Congenital HemangiomaHemangioendotheliomaAngiosarcoma+1 more
NCT01877187Phase 2Completed

Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer

Started Apr 2013
39 enrolled
Liver Cancer